C. Faucher

发表

Nodrm-1, a Sulphated Lipo-Oligosaccharide Signal of Rhizobium Meliloti Elicits Hair Deformation, Cortical Cell Division and Nodule Organogenesis on Alfalfa Roots

P. Lerouge, J. Vasse, S. Camut, 1991 .

An Extracellular Oligosaccharide Symbiotic Signal Produced by Rhizobium Meliloti

P. Lerouge, G. Truchet, J. Dénarié, 1991 .

Molecular basis of symbiotic host specificity in rhizobium meliloti: nodH and nodPQ genes encode the sulfation of lipo-oligosaccharide signals

P. Lerouge, G. Truchet, J. Dénarié, 1991, Cell.

Symbiotic host-specificity of Rhizobium meliloti is determined by a sulphated and acylated glucosamine oligosaccharide signal

Philippe Roche, Jean Dénarié, P. Lerouge, 1990, Nature.

Rhizobium meliloti nodulation genes specify the production of an alfalfa-specific sulfated lipo-oligosaccharide signal

P. Lerouge, J. Vasse, S. Camut, 1990 .

The Common Nodabc Genes and the Nodh and Nodq Host-Range Genes of Rhizobium Meliloti Determine the Production of Low Molecular Weight Extracellular Signals

Shashi Sharma, P. Lerouge, J. Vasse, 1989 .

Rhizobium meliloti host range nodH gene determines production of an alfalfa-specific extracellular signal

J. Vasse, G. Truchet, J. Dénarié, 1988, Journal of bacteriology.

Analysis of donor NK and T cells infused in patients undergoing MHC-matched allogeneic hematopoietic transplantation

D. Blaise, C. Chabannon, É. Vivier, 2002, Leukemia.

Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients.

D. Blaise, Wang LiNing, R. Devillier, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient

G. Damaj, N. Vey, C. Faucher, 2004, Annals of Hematology.

The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

D. Blaise, R. Devillier, S. Harbi, 2017, Bone Marrow Transplantation.

A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society

J. Bourhis, H. Dombret, A. Baruchel, 2003, Bone Marrow Transplantation.

New developments in the use of apheresis to collect haematopoietic cells for cell transplantation and cell therapies

C. Chabannon, C. Faucher, A. Granata, 2016 .

Feasibility of High Dose Melphalan (140 mg/m2) and Peripheral Blood Stem Cell Support as Consolidation for Patients over 60 Years with Acute Myeloid Leukemia in First Complete Remission

R. Bouabdallah, D. Blaise, D. Coso, 2003 .

TLI in refractory chronic GVHD

D. Blaise, R. Devillier, L. Castagna, 2013, Bone Marrow Transplantation.

Transient detection of β-galactosidase activity in hematopoietic cells, following reinjection of retrovirally marked autologous blood progenitors in patients with breast or ovarian cancer receiving high-dose chemotherapy

D. Blaise, P. Viens, G. Gravis, 2002 .

T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes

D. Blaise, C. Carlo-Stella, R. Devillier, 2016, Bone Marrow Transplantation.

Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT

D. Blaise, D. Coso, C. Chabannon, 2013, Bone Marrow Transplantation.

Reduced‐intensity conditioning allogeneic stem cell transplantation for patients with chemoresistant or relapsed follicular lymphoma

R. Bouabdallah, L. Xerri, D. Blaise, 2006, British journal of haematology.

Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen.

D. Olive, D. Blaise, M. Mohty, 2003, Experimental hematology.

Accreditation and regulations in cell therapy

E. Rial‐Sebbag, C. Chabannon, I. Slaper-Cortenbach, 2016 .

Long‐term outcome after allogeneic stem‐cell transplantation with reduced‐intensity conditioning in patients with multiple myeloma

R. Bouabdallah, D. Blaise, D. Coso, 2013, American journal of hematology.

High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results

F. Bertucci, P. Viens, G. Houvenaeghel, 2000, Bone Marrow Transplantation.

Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a ‘donor’ versus ‘no donor’ comparison

D. Blaise, M. Mohty, D. Coso, 2009, Leukemia.

Autologous cord blood use: Clinical and scientific aspects

D. Latinne, A. Ferrant, Y. Benoît, 2011 .

Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma

A. Santoro, D. Blaise, C. Carlo-Stella, 2018, Bone Marrow Transplantation.

Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial.

D. Cowen, M. Schubert, C. Faucher, 1997, International journal of radiation oncology, biology, physics.

Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplant

B. Esterni, D. Blaise, M. Mohty, 2010, Leukemia & lymphoma.

OF ANTIBIOTICS AN INHIBITOR OF MAMMALIANCOLLAGENASE ACTIVE AT MICROMOLAR CONCENTRATIONS FROM AN ACTINOMYCETE CULTURE BROTH

C. Faucher, Terence, Y. Lelièvre, 2006 .

OPTIMIZATION OF PERIPHERAL BLOOD STEM CELL COLLECTION BY LEUKOPHERESIS

J. Blache, D. Blaise, C. Chabannon, 1999, International Journal of Technology Assessment in Health Care.

Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery.

R. Bouabdallah, D. Blaise, P. Viens, 1996, Journal of hematotherapy.

Patient condition affects the collection of peripheral blood progenitors after priming with recombinant granulocyte colony-stimulating factor.

D. Blaise, C. Chabannon, D. Maraninchi, 1995, Journal of hematotherapy.

Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients

D. Blaise, P. Viens, J. Bay, 2002, Bone Marrow Transplantation.

Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors.

D. Blaise, M. Mohty, V. Bardou, 2004, Blood.

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

R. Bouabdallah, D. Blaise, M. Mohty, 2000, Bone Marrow Transplantation.

Graft-versus-host-disease and granulocyte colony-stimulating factor administration after allogeneic stem cell transplantation

D. Blaise, M. Mohty, C. Faucher, 2005, Leukemia.

Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case report

D. Olive, D. Blaise, M. Mohty, 2001, Bone Marrow Transplantation.

Direct evidence for dissociated megakaryocytic chimaerism in a Wiskott‐Aldrich patient successfully allografted

D. Blaise, C. Arnoulet, D. Maraninchi, 1995, British journal of haematology.

The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide

A. Santoro, D. Blaise, C. Carlo-Stella, 2019, Bone Marrow Transplantation.

Randomized study of 2 reduced‐intensity conditioning strategies for human leukocyte antigen‐matched, related allogeneic peripheral blood stem cell transplantation

D. Blaise, M. Mohty, V. Bardou, 2013, Cancer.

Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantation

D. Olive, D. Blaise, M. Mohty, 2005, Leukemia.

Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation

D. Blaise, M. Mohty, D. Coso, 2004, Bone Marrow Transplantation.

High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study.

K. Cornetta, D. Blaise, M. Shlomchik, 1998, British Journal of Cancer.

Transplantation of allogeneic CD34+ blood cells in leukemia or lymphoma patients at high risk of GVHD

D. Blaise, C. Chabannon, F. Viret, 1999, Bone Marrow Transplantation.

Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT

R. Bouabdallah, D. Blaise, C. Oudin, 2013, Bone Marrow Transplantation.

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

H. Einsele, C. Heussel, P. Ljungman, 2010, Haematologica.

Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first‐line treatment

D. Blaise, M. Mohty, D. Coso, 2005, Cancer.

HLA phenotypes of candidates for HSCT: comparing transplanted versus non-transplanted candidates, resulting in the predictive estimation of the probability to find a 10/10 HLA matched donor.

P. Gourraud, P. Loiseau, C. Faucher, 2014, Tissue antigens.

Recovery of Lymphocyte and Dendritic Cell Subsets Following Reduced Intensity Allogeneic Bone Marrow Transplantation

R. Bouabdallah, D. Olive, D. Blaise, 2002, Hematology.

Inolimomab in Steroid-Refractory Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation: Retrospective Analysis and Comparison with Other Interleukin-2 Receptor Antibodies

A. Fischer, A. Stamatoullas, I. Yakoub-Agha, 2005, Transplantation.

Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement.

R. Bouabdallah, D. Blaise, N. Vey, 1999, Hematology and cell therapy.

Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study.

M. Robin, M. Mohty, N. Vey, 2008, International journal of antimicrobial agents.

showed to be effective in preventing bleeding events.

D. Blaise, C. Oudin, C. Chabannon, 2013 .

Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myeloma

R. Bouabdallah, B. Esterni, D. Blaise, 2013, Leukemia and Lymphoma.

Cost effectiveness of day 5 G-CSF (Lenograstim®) administration after PBSC transplantation: results of a SFGM-TC randomised trial

J. Bourhis, C. Gisselbrecht, A. Aupérin, 2005, Bone Marrow Transplantation.

Administration of G-CSF can be delayed after transplantation of autologous G-CSF-primed blood stem cells: a randomized study.

D. Blaise, C. Chabannon, D. Maraninchi, 1996, Bone marrow transplantation.

Evidence for anti-tumour effect of allogeneic haematopoietic SCT in cases without sustained donor engraftment

M. Robin, E. Deconinck, P. Tiberghien, 2010, Bone Marrow Transplantation.

HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison.

D. Blaise, R. Devillier, S. Harbi, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation.

R. Bouabdallah, D. Olive, D. Blaise, 2005, Blood.

Cost-effectiveness analysis of haploidentical vs matched unrelated allogeneic hematopoietic stem cells transplantation in patients older than 55 years

D. Blaise, R. Touzani, R. Devillier, 2018, Bone Marrow Transplantation.

High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation

R. Bouabdallah, D. Blaise, M. Mohty, 2007, Bone Marrow Transplantation.

Purification and characterization of two basic beta-1,3-glucanases induced in Colletotrichum lindemuthianum-infected bean seedlings.

C. Lafitte, A. Touzé, C. Faucher, 1992, Archives of biochemistry and biophysics.

Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation.

D. Blaise, M. Mohty, P. Viens, 2010, Experimental hematology.

CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies.

N. Kröger, D. Blaise, C. Chabannon, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: a retrospective monocentre study on 547 patients.

R. Bouabdallah, D. Blaise, C. Oudin, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.

D. Blaise, R. Devillier, S. Harbi, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The efficacy and safety of a new reduced-toxicity conditioning with 4 days of once-daily 100 mg/m2 intravenous busulfan associated with fludarabine and antithymocyte globulins prior to allogeneic stem cell transplantation in patients with high-risk myelodysplastic syndrome or acute leukemia

D. Blaise, R. Devillier, S. Harbi, 2016, Leukemia & lymphoma.

Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies.

R. Bouabdallah, B. Esterni, D. Blaise, 2010, Experimental hematology.

Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation.

D. Blaise, M. Mohty, P. Viens, 2007, Haematologica.

Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level

R. Bouabdallah, D. Blaise, M. Mohty, 2004, Transfusion.

Impact of Pretransplant Donor and Recipient Cytomegalovirus Serostatus on Outcome for Multiple Myeloma Patients Undergoing Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

R. Bouabdallah, D. Blaise, R. Devillier, 2012, Mediterranean journal of hematology and infectious diseases.

Algorithm based on CMV kinetics DNA viral load for preemptive therapy initiation after hematopoietic cell transplantation

P. Halfon, G. Pénaranda, H. Khiri, 2011, Journal of medical virology.

Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen

D. Olive, D. Blaise, M. Mohty, 2003, Leukemia.

Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia.

D. Blaise, M. Mohty, N. Vey, 2007, Haematologica.

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen.

D. Blaise, M. Mohty, P. Viens, 2003, Blood.

Parvovirus B19 as an etiological agent of acute pleuro-pericarditis

D. Blaise, L. Castagna, C. Faucher, 2011, Bone Marrow Transplantation.

Comparable outcomes between unrelated and related donors after reduced‐intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high‐risk multiple myeloma

R. Bouabdallah, D. Blaise, D. Coso, 2012, European journal of haematology.

Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma

R. Bouabdallah, D. Blaise, M. Mohty, 2008, Bone Marrow Transplantation.

T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors.

R. Bouabdallah, A. Santoro, D. Blaise, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma

R. Bouabdallah, A. Santoro, D. Blaise, 2017, Bone Marrow Transplantation.

The nodH and nodQ host range genes of Rhizobium meliloti behave as avirulence genes in R. leguminosarum bv. viciae and determine changes in the production of plant-specific extracellular signals

S. Camut, G. Truchet, J. Dénarié, 1989 .

Psychosocial aspects of haematopoietic stem cell donation for allogeneic transplantation: how family donors cope with this experience

D. Blaise, J. Moatti, D. Maraninchi, 1999, Psycho-oncology.

Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies: a pilot study

D. Blaise, C. Chabannon, D. Maraninchi, 1998, Bone Marrow Transplantation.

Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institution.

R. Bouabdallah, D. Blaise, P. Viens, 1998, Leukemia & lymphoma.

Umbilical cord blood transplants facilitated by the French cord blood banks network. On behalf of the Agency of Biomedicine, Eurocord and the French society of bone marrow transplant and cell therapy (SFGM-TC)

J. Larghero, J. de Vos, J. Bay, 2021, Bone Marrow Transplantation.

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation

J. Bourhis, D. Blaise, M. Mohty, 2003, Leukemia.

Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation

R. Bouabdallah, B. Esterni, D. Blaise, 2005, Bone Marrow Transplantation.

Early establishment of chimerism in the B and T lymphoid lineages after transplantation of allogeneic mobilized blood cells in leukemic patients.

D. Blaise, C. Chabannon, D. Maraninchi, 1997, Transplantation.

Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis

D. Olive, D. Blaise, M. Mohty, 2002, Leukemia.

Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unit.

J. Blache, D. Blaise, L. Castagna, 2015, Journal of critical care.

A matched‐pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institution

D. Blaise, R. Devillier, S. Harbi, 2019, Transfusion.

CD34(+) immunoselected cells for poor graft function following allogeneic BMT.

R. Bouabdallah, D. Blaise, M. Mohty, 2000, Cytotherapy.

National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine–busulfan–antithymocyte globulin conditioning regimen

D. Blaise, C. Oudin, C. Chabannon, 2014, Leukemia & lymphoma.

Cost–effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation

D. Blaise, P. Viens, N. Vey, 2003, Leukemia.

Bone marrow and blood cells as alternative sources of hematopoietic progenitors after failure of a first collection. A single institution retrospective study.

D. Blaise, P. Viens, C. Chabannon, 1996, Transplantation.

High response rate and improved graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic stem cell transplantation for multiple myeloma

D. Blaise, A. Nagler, M. Mohty, 2008, Haematologica.

Healthy sibling donor anxiety and pain during bone marrow or peripheral blood stem cell harvesting for allogeneic transplantation: results of a randomised study

D. Blaise, N. Milpied, C. Faucher, 2002, Bone Marrow Transplantation.

Comparison of G-CSF-primed peripheral blood progenitor cells and bone marrow auto transplantation: clinical assessment and cost-effectiveness.

D. Blaise, D. Maraninchi, C. Faucher, 1994, Bone Marrow Transplantation.

Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide.

A. Santoro, D. Blaise, C. Carlo-Stella, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor.

R. Bouabdallah, D. Blaise, R. Devillier, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Quality controls on cord blood unit contiguous segments: recommendation of the SFGM-TC.

I. Yakoub-Agha, J. Larghero, J. de Vos, 2014, Pathologie-biologie.

Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation

D. Blaise, M. Mohty, P. Viens, 2004, Bone Marrow Transplantation.

R. Bouabdallah, A. Santoro, D. Blaise, 2015, Cancer.

Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France

M. Labopin, I. Yakoub-Agha, D. Blaise, 2014, Haematologica.

Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donor

J. Bourhis, P. Chevallier, I. Yakoub-Agha, 2019, Bone Marrow Transplantation.

Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs

B. Esterni, D. Blaise, M. Mohty, 2012, Bone Marrow Transplantation.

Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myeloma.

D. Blaise, C. Oudin, C. Chabannon, 2012, Experimental hematology.

Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients

R. Bouabdallah, D. Blaise, R. Devillier, 2018, Bone Marrow Transplantation.

The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide

R. Bouabdallah, A. Santoro, D. Blaise, 2016, Bone Marrow Transplantation.

CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.

D. Olive, D. Blaise, M. Mohty, 2004, Experimental hematology.

Autologous stem cell transplantation for acute myelogenous leukemia in first complete remission: a 6-year follow-up study of 101 patients from a single institution

R. Bouabdallah, D. Blaise, N. Vey, 2004, Bone Marrow Transplantation.

Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies

B. Esterni, P. Chevallier, D. Blaise, 2014, Haematologica.

Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patients

R. Bouabdallah, D. Blaise, R. Devillier, 2019, Bone Marrow Transplantation.

Long-Term Outcome of Second Allogeneic Hematopoietic Stem Cell Transplantation as Salvage Therapy for Young Patients after Relapse or Graft Failure: Experience at a Single Institution

D. Blaise, M. Mohty, N. Vey, 2013 .

Double reduced-intensity allogeneic hematopoietic stem cell transplantation: a retrospective study from the SFGM-TC.

M. Robin, P. Chevallier, D. Blaise, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Delayed administration of granulocyte colony-stimulating factor after autologous bone marrow transplantation: effect on granulocyte recovery.

R. Bouabdallah, P. Viens, N. Vey, 1994, Bone marrow transplantation.

Clinical and economic comparison of lenograstim-primed blood cells (BC) and bone marrow (BM) allogeneic transplantation.

D. Blaise, P. Viens, J. Moatti, 1998, Bone marrow transplantation.

High-dose chemotherapy with hematopoietic stem cell support in patients with advanced epithelial ovarian cancer: analysis of 67 patients treated in a single institution.

F. Bertucci, D. Blaise, P. Viens, 1999, Anticancer research.

Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation

D. Blaise, C. Oudin, C. Chabannon, 2012, American journal of hematology.

JC Virus Leuko-Encephalopathy in Reduced Intensity Conditioning Cord Blood Transplant Recipient with a Review of the Literature

D. Blaise, C. Oudin, L. Castagna, 2012, Mediterranean Journal of Hematology and Infectious Diseases.

onditioning Cord Blood

D. Blaise, C. Oudin, L. Castagna, 2012 .

JC Virus Leuko-Encephalopathy Transplant Recipient with a R

C. Oudin, L. Castagna, C. Faucher, 2012 .

Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma.

R. Bouabdallah, A. Santoro, D. Blaise, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Massive ascites of donor T-cell origin in a patient with acute GVHD after a reduced-intensity allograft for CLL

D. Blaise, M. Mohty, N. Vey, 2003, Bone Marrow Transplantation.

Rituximab as salvage therapy for refractory chronic GVHD

D. Blaise, M. Mohty, N. Marchetti, 2008, Bone Marrow Transplantation.

Features of extramedullary and extraosseous multiple myeloma: a report of 19 patients from a single center

R. Bouabdallah, M. Mohty, G. Damaj, 2004, European journal of haematology.

Prior rituximab administration is associated with reduced rate of acute GVHD after in vivo T-cell depleted transplantation in lymphoma patients.

R. Bouabdallah, D. Blaise, D. Coso, 2011, Experimental hematology.

Donor CD3(+) lymphocyte infusion after reduced intensity conditioning allogeneic stem cell transplantation: single-center experience.

R. Bouabdallah, D. Blaise, C. Oudin, 2013, Experimental hematology.

Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

M. Robin, I. Yakoub-Agha, M. Mohty, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin’s lymphoma

R. Bouabdallah, D. Blaise, C. Oudin, 2013, Bone Marrow Transplantation.

Autologous Peripheral Blood Progenitor-Cell Transplantation versus Autologous Bone Marrow Transplantation for Adults and Children with Non-Leukaemic Malignant Disease

D. Blaise, J. Moatti, A. Aupérin, 1997, PharmacoEconomics.

[Comparative study of the costs for two hematopoietic cell specimen collections: cytapheresis and bone marrow collection].

J. Blache, P. Auquier, D. Blaise, 1996, Revue d'epidemiologie et de sante publique.

Decreased Expression of the Membrane Inhibitor of Complement‐Mediated Cytolysis CD59 on T‐lymphocytes of HIV‐Infected Patients

M. Kazatchkine, H. Okada, T. Hattori, 1992, AIDS.

The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT

B. Esterni, D. Blaise, R. Devillier, 2012, Bone Marrow Transplantation.

Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens

D. Blaise, M. Mohty, P. Moreau, 2008, Bone Marrow Transplantation.

A pilot study of busulfan and melphalan as preparatory regimen prior to allogeneic bone marrow transplantation in refractory or relapsed hematological malignancies.

R. Bouabdallah, D. Blaise, N. Vey, 1996, Bone marrow transplantation.

Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen

D. Olive, D. Blaise, M. Mohty, 2004, Bone Marrow Transplantation.

The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison

D. Blaise, M. Mohty, D. Coso, 2005, Leukemia.

Non-myeloablative allogeneic stem cell transplantation (NST) for metastatic melanoma: nondurable chemotherapy responses without clinically meaningful graft-vs-tumor (GVT) effects.

E. Leifer, N. Geller, R. Srinivasan, 2002 .

Low-dose methotrexate as salvage therapy for refractory graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation.

D. Blaise, M. Mohty, H. de Lavallade, 2006, Haematologica.

Response to immunosuppressive treatment predicts outcome in patients with chronic graft-versus-host disease: a single-center analysis of longitudinal data.

M. Sormani, D. Blaise, C. Oudin, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission

R. Bouabdallah, D. Blaise, M. Mohty, 2006, Bone Marrow Transplantation.

Long-term graft-versus-Waldenström macroglobulinemia effect following reduced intensity conditioning allogeneic stem cell transplantation

R. Bouabdallah, D. Blaise, M. Mohty, 2007, Bone Marrow Transplantation.

Current update on reduced intensity regimens for allogeneic stem cell transplantation

D. Olive, D. Blaise, M. Mohty, 2005, Hematology.

Acute lysis pneumopathy after chemotherapy for acute myelomonocytic leukemia with abnormal marrow eosinophils

H. Dombret, L. Degos, C. Faucher, 1992, Cancer.

Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide

D. Blaise, L. Giordano, C. Carlo-Stella, 2016, Bone Marrow Transplantation.

Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies: a retrospective bicentric analysis of serial infusions of increasing doses of CD3+ cells

D. Blaise, R. Devillier, S. Harbi, 2018, British journal of haematology.

Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML

D. Blaise, R. Devillier, S. Harbi, 2017, Bone Marrow Transplantation.

Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: a comparative retrospective single-center study.

S. Ranque, B. Esterni, D. Blaise, 2010, Hematology/oncology and stem cell therapy.

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma

R. Bouabdallah, A. Santoro, D. Blaise, 2017, Bone Marrow Transplantation.

Allogeneic transplant for myeloma in the era of new drugs: have the outcomes improved?

R. Bouabdallah, D. Blaise, M. Mohty, 2012, Leukemia & lymphoma.

Comparison of Three Distinct Prophylactic Agents Against Invasive Fungal Infections in Patients Undergoing Haplo-identical Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

R. Bouabdallah, A. Santoro, D. Blaise, 2015, Mediterranean journal of hematology and infectious diseases.

Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors

B. Esterni, D. Blaise, D. Coso, 2014, Bone Marrow Transplantation.

Killer Cell Immunoglobulin-Like Receptor-Ligand Mismatch in Donor versus Recipient Direction Provides Better Graft-versus-Tumor Effect in Patients with Hematologic Malignancies Undergoing Allogeneic T Cell-Replete Haploidentical Transplantation Followed by Post-Transplant Cyclophosphamide.

D. Blaise, R. Devillier, S. Harbi, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T-Replete Haploidentical Allogeneic Transplantation Using Post-Transplantation Cyclophosphamide in Advanced Acute Myeloid Leukemia and Myelodysplastic Syndromes

A. Santoro, D. Blaise, R. Devillier, 2016 .

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Acute Myeloid Leukemia (AML): Long Term Results of a “Donor” Versus “No Donor” Comparison.

D. Blaise, M. Mohty, D. Coso, 2007 .

Older age does not influence allogeneic peripheral blood stem cell mobilization in a donor population of mostly white ethnic origin.

D. Blaise, C. Chabannon, H. de Lavallade, 2009, Blood.

Low incidence of chronic GVHD after HLA‐haploidentical peripheral blood stem cell transplantation with post‐transplantation cyclophosphamide in older patients

D. Blaise, R. Devillier, S. Harbi, 2017, British journal of haematology.

Secondary Malignant Non-Rhabdomyosarcoma Soft Tissue Sarcomas After Hematopoietic Stem Cell Transplantation in Childhood for Acute Leukemia

S. Salas, C. Bouvier, N. Macagno, 2019 .

Immune reconstitution after blood cell transplantation.

D. Blaise, C. Arnoulet, C. Chabannon, 1997, Hematology and cell therapy.

Rescue of haemopoiesis by a combination of growth factors including stem-cell factor

D. Blaise, N. Vey, C. Chabannon, 2000, The Lancet.

Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia

D. Blaise, R. Devillier, J. Rey, 2013, Leukemia & lymphoma.

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) as Salvage Treatment for Relapsing Multiple Myeloma (MM): A “Donor” vs. “No Donor” Comparison.

R. Bouabdallah, D. Blaise, M. Mohty, 2006 .

Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT

R. Bouabdallah, B. Esterni, D. Blaise, 2011, Bone Marrow Transplantation.

Prospective Randomized Comparison of Reduced Intensity (FLU-BU-ATG) and Non-Myeloablative (FLU-TBI) Conditioning for Genoidentical Allo-SCT: a Clinical and economical Multicenter Itac Study.

D. Blaise, M. Mohty, J. Bay, 2009 .

N-terminal pro-brain natriuretic peptide as an early prognostic factor in cancer patients developing septic shock

J. Blache, D. Blaise, C. Faucher, 2007, Critical care.

Impact of CD34‐positive cell dose on outcome after peripheral blood stem cell allogeneic transplantation prepared with ATG‐based reduced intensity conditioning regimen

D. Blaise, R. Devillier, S. Harbi, 2017, American journal of hematology.

OP18. Optimization of peripheral blood stem cell collection (PBSC) by leukapheresis: a case of interaction between economic and clinical assessment of an innovation

C. Chabannon, D. Maraninchi, C. Faucher, 1997 .

[Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

P. Vermersch, J. Bourhis, I. Yakoub-Agha, 2017, Bulletin du Cancer.

[Autologous stem cell transplantation for autoimmune diseases: recommendations from the SFGM-TC].

P. Vermersch, I. Yakoub-Agha, D. Farge, 2014, Pathologie et biologie.

Severe chloroquine-resistant falciparum malaria in Gabon with decreased sensitivity to quinine.

J. Le bras, F. Simon, F. Pichon, 1986, Transactions of the Royal Society of Tropical Medicine and Hygiene.

The Role of Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (Allo-SCT) in Patients with Acute Myeloid Leukemia (AML): A Donor vs. No Donor Comparison.

D. Blaise, M. Mohty, D. Coso, 2004 .

Comparison of anxiety, pain and discomfort in two procedures of hematopoietic stem cell collection: leukacytapheresis and bone marrow harvest.

J. Blache, P. Auquier, D. Blaise, 1995, Bone marrow transplantation.

Impact of antithymocyte globulin on the need for platelet transfusions during reduced-intensity conditioning administration before allogeneic stem cell transplantation.

D. Blaise, C. Oudin, C. Chabannon, 2013, Experimental hematology.

[Definition and standardization of histocompatibility requests depending on patient course and donor type: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) and the Francophone Society of Histocompatibility and Immunogenetics (SFHI)].

I. Yakoub-Agha, V. Dubois, C. Faucher, 2021, Bulletin du cancer.

D. Blaise, R. Devillier, S. Harbi, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[Allogeneic hematopoietic cell transplantation in solid tumors].

D. Blaise, J. Bay, O. Tournilhac, 2001, Bulletin du cancer.

R. Bouabdallah, A. Santoro, D. Blaise, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic transplant for myeloma in the era of new drugs: have the outcomes improved?

R. Bouabdallah, D. Blaise, M. Mohty, 2012, Leukemia & lymphoma.

[Stem cell transplantation unit: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].

I. Yakoub-Agha, L. Mannone, N. Loukili, 2019, Bulletin du cancer.

Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: A feasibility study in patients with poor-risk breast cancer and receiving high-doses of cyclophosphamide.

J. Blache, D. Blaise, P. Viens, 1999, International journal of oncology.

Randomized study of 2 reduced‐intensity conditioning strategies for human leukocyte antigen‐matched, related allogeneic peripheral blood stem cell transplantation

D. Blaise, M. Mohty, V. Bardou, 2013, Cancer.

Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors

B. Esterni, D. Blaise, D. Coso, 2014, Bone Marrow Transplantation.

R. Bouabdallah, D. Blaise, R. Devillier, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.